Applied Therapeutics Inc (NAS:APLT)
$ 4.28 -0.12 (-2.73%) Market Cap: 489.06 Mil Enterprise Value: 356.63 Mil PE Ratio: 0 PB Ratio: 7.47 GF Score: 39/100

Applied Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript

May 25, 2021 / 02:00PM GMT
Release Date Price: $18.65 (+7.06%)
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

My name is Navin Jacob, I cover SMID cap biotech and pharma here at UBS. Happy to have with me for our next session of Applied Therapeutics CEO Shoshana Shendelman; as well as CFO, Chuck Silberstein. We're happy to have both of them here to provide a short presentation on Applied Therapeutics. For those who are not familiar with it, it's a great way to learn about the company. We'll spend about 30 minutes going through those slides. And then the last 15 minutes, I will moderate a Q&A session with Shoshana and Chuck. And without further ado, Shoshana, please take it away.

Shoshana Shendelman
Applied Therapeutics, Inc. - Chair of the Board of Directors, Founder, President, CEO & Secretary

Thanks very much, Navin. So as you said, I think it might be helpful to just give a little bit of background on Applied Therapeutics. We are a late-stage pharmaceutical company based in New York City. And our business strategy is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot